SIM
ROSG

Spark Investment Management’s Rosetta Genomics Ltd. ROSG Stock Holding History

Spark Investment Management’s Portfolio ROSG Stock Details ROSG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-1,917
Closed -$70K – 808
2015
Q1 		$70K Sell
1,917
-25
-1% -$947 0.01% 650
2014
Q4 		$52K Buy
1,942
+1,000
+106% +$32.5K 0.01% 640
2014
Q3 		$39K Hold
942
– – 0.01% 644
2014
Q2 		$48K Sell
942
-3,391
-78% -$168K 0.01% 598
2014
Q1 		$258K Buy
4,333
+1,591
+58% +$82.1K 0.04% 473
2013
Q4 		$94K Buy
+2,742
New +$95.2K 0.02% 563

Other funds holding ROSG

HCM
Highlander Capital Management Short Hills, New Jersey $292M AUM 22.24% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
ICAS
Investors Capital Advisory Services Lynnfield, Massachusetts $521M AUM 1.51% 1-Year Est. Return
RCM
Rotella Capital Management Bellevue, Washington $1.47M AUM 12.32% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Spark Investment Management's ROSG Position: Q2 2015 in Review

Spark Investment Management sold out of Rosetta Genomics Ltd. (ROSG) in Q2 2015, closing a stake of 1,917 shares — an estimated $70K sold.

Spark Investment Management first reported a position in ROSG in Q4 2013 and held it in 6 quarters. The position peaked at $258K in Q1 2014. 11 funds tracked by Wall St. Rank hold ROSG as of Q2 2015.

  • Spark Investment Management reported no remaining Rosetta Genomics Ltd. position as of Q2 2015 after selling out during the quarter.
  • Spark Investment Management sold 1,917 Rosetta Genomics Ltd. shares in Q2 2015, an estimated $70K.
  • Spark Investment Management first reported a position in Rosetta Genomics Ltd. in Q4 2013 and held it in 6 quarters.
  • Spark Investment Management's Rosetta Genomics Ltd. position peaked at $258K in Q1 2014.
  • 11 funds tracked by Wall St. Rank held Rosetta Genomics Ltd. as of Q2 2015.

Based on Spark Investment Management's 13F filing for Q2 2015, filed 12 Aug 2015.